NeurotechMagProGet access
Patent Filing

Implantable lead location using ECAP

Medtronic, Inc.5/27/2025ยท05/27/25๐ŸŒ USA

Summary

This patent describes techniques for determining the location of implanted neurostimulation leads using evoked compound action potentials (ECAPs). The system measures neural responses to stimulation to verify lead placement and optimize therapy delivery in deep brain stimulation, peripheral nerve stimulation, and other applications.

Why it matters

Accurate lead placement verification is essential for effective neurostimulation therapy. This ECAP-based positioning technology helps Medtronic's clinicians optimize lead placement during surgery and post-operatively, improving therapy outcomes and reducing the need for revision surgeries, which strengthens Medtronic's competitive position.

#Neurostimulation#Deep Brain Stimulation#Neural Recording#Closed-Loop#USA

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in